Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Astrazeneca (AZN) Share News

LONDON MARKET CLOSE: Stocks on the back foot ahead of nonfarm payrolls

5th Sep 2024 16:59

(Alliance News) - Stocks faded into the close on Thursday to end in the red weighed by a drop in index heavyweight AstraZeneca on a day of mixed news for blue-chips. Read More

China probing AstraZeneca employees for potential illegal acts

5th Sep 2024 11:13

(Alliance News) - Several employees of multinational pharmaceutical firm AstraZeneca PLC are under investigation in China, the firm told AFP Thursday, after a report said they were being questioned about potentially illegal data collection and drug imports. Read More

LONDON BROKER RATINGS: UBS raises Sage Group to 'neutral'

5th Sep 2024 10:00

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More

UK dividends calendar - next 7 days

2nd Sep 2024 12:21

TOP NEWS: AstraZeneca asthma drug Fasenra gets approval in China

20th Aug 2024 08:56

(Alliance News) - AstraZeneca PLC on Tuesday announced that China's National Medical Products Association has approved benralizumab to treat patients aged 12 and older with severe eosinophilic asthma. Read More

LONDON BRIEFING: Gran Tierra makes GBP174 million offer for i3 Energy

20th Aug 2024 07:49

(Alliance News) - Stocks in London are called to open lower on Tuesday, as investors look ahead to a key inflation reading from the eurozone. Read More

AstraZeneca and Daiichi Sankyo gets US and European nods for Enhertu

19th Aug 2024 09:31

(Alliance News) - Daiichi Sankyo Co Ltd on Monday announced positive updates for Enhertu, with the cancer drug receiving support from US and European regulators. Read More

AstraZeneca's Infinzi gets US approval for treatment of lung cancer

16th Aug 2024 08:27

(Alliance News) - AstraZeneca PLC on Friday said Imfinzi has been approved in the US for the treatment of resectable non-small cell lung cancer before and after surgery. Read More

TOP NEWS: AstraZeneca's Imfinzi secures US priority review for cancer

15th Aug 2024 08:56

(Alliance News) - AstraZeneca PLC on Thursday said Imfinzi has been granted priority review and breakthrough therapy designation for patients with limited-stage small cell lung cancer in the US. Read More

LONDON MARKET OPEN: FTSE 100 green but other stocks suffer on GDP data

15th Aug 2024 08:34

(Alliance News) - Stock prices in London opened a mixed bag on Thursday, with the FTSE 100 in the green but others trailing behind, after data showed no monthly growth in the UK economy. Read More

LONDON MARKET MIDDAY: Stocks stay upbeat ahead of US CPI data

14th Aug 2024 11:51

(Alliance News) - Stock prices in London were higher at midday on Wednesday, as the market remained optimistic following a UK CPI print in the morning, and ahead of one from the US later in the afternoon. Read More

TOP NEWS: AstraZeneca celebrates EU approval of Lynparza plus Imfinzi

14th Aug 2024 09:16

(Alliance News) - AstraZeneca PLC on Wednesday said that the EU approved Imfinzi in combination with Lynparza for a form of cancer. Read More

LONDON MARKET OPEN: Stocks stay green as UK CPI stirs cut speculation

14th Aug 2024 08:36

(Alliance News) - Stock prices in London started the day in the green, even after local economic data showed an acceleration in UK consumer price inflation for the first time since December. Read More

LONDON MARKET MIDDAY: Stocks turn red as sentiment sours before US PPI

13th Aug 2024 11:52

(Alliance News) - Stock prices in London were in the red at midday, as investor sentiment turned ahead of the next inflationary print from the US this afternoon. Read More

AstraZeneca and Daiichi Sankyo get new approval in China for Enhertu

13th Aug 2024 11:38

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Tuesday said their joint product Enhertu has received a third approval in China. Read More

UK dividends calendar - next 7 days

1st Aug 2024 14:32

IN BRIEF: AstraZeneca prices EUR1.4 billion in bonds at 3.1% and 3.3%

30th Jul 2024 15:59

AstraZeneca PLC - Cambridge, England-based biopharmaceutical maker - Prices two tranches of eurobonds, raising a total of EUR1.40 billion for "general corporate purposes". Issues EUR650 million in fixed-rate notes with a coupon of 3.121% maturing in August 2030, and EUR750 million in fixed-rate notes with a coupon of 3.278% maturing in August 2033. The offering, by subsidiary AstraZeneca Finance LLC, is run by BNP Paribas, Goldman Sachs International, Morgan Stanley and Societe Genarale as joint book-running managers. Read More

FTSE 100 Latest

Value8,809.74

Change53.53